Correlation Between Nykode Therapeutics and Equinor ASA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nykode Therapeutics and Equinor ASA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nykode Therapeutics and Equinor ASA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nykode Therapeutics ASA and Equinor ASA, you can compare the effects of market volatilities on Nykode Therapeutics and Equinor ASA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nykode Therapeutics with a short position of Equinor ASA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nykode Therapeutics and Equinor ASA.

Diversification Opportunities for Nykode Therapeutics and Equinor ASA

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Nykode and Equinor is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Nykode Therapeutics ASA and Equinor ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equinor ASA and Nykode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nykode Therapeutics ASA are associated (or correlated) with Equinor ASA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equinor ASA has no effect on the direction of Nykode Therapeutics i.e., Nykode Therapeutics and Equinor ASA go up and down completely randomly.

Pair Corralation between Nykode Therapeutics and Equinor ASA

Assuming the 90 days trading horizon Nykode Therapeutics ASA is expected to under-perform the Equinor ASA. In addition to that, Nykode Therapeutics is 2.77 times more volatile than Equinor ASA. It trades about -0.08 of its total potential returns per unit of risk. Equinor ASA is currently generating about 0.01 per unit of volatility. If you would invest  25,737  in Equinor ASA on September 3, 2024 and sell it today you would earn a total of  983.00  from holding Equinor ASA or generate 3.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nykode Therapeutics ASA  vs.  Equinor ASA

 Performance 
       Timeline  
Nykode Therapeutics ASA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nykode Therapeutics ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Equinor ASA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equinor ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent essential indicators, Equinor ASA is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Nykode Therapeutics and Equinor ASA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nykode Therapeutics and Equinor ASA

The main advantage of trading using opposite Nykode Therapeutics and Equinor ASA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nykode Therapeutics position performs unexpectedly, Equinor ASA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equinor ASA will offset losses from the drop in Equinor ASA's long position.
The idea behind Nykode Therapeutics ASA and Equinor ASA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
CEOs Directory
Screen CEOs from public companies around the world
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk